Testicular cancer is one of the most treatable cancers. The overall five-year survival rate is 99% when it’s caught before spreading beyond the testicle, and even cancers that have spread to distant organs still have a 72% five-year survival rate. About 9,810 new cases are expected in the U.S. in 2026, with roughly 630 deaths, making it relatively rare and far less deadly than most other cancers.
That said, “how bad” depends on several factors: how early it’s found, what type it is, whether it has spread, and what treatment involves. The cancer itself may be highly curable, but the treatment journey can carry real costs to your body, fertility, and quality of life.
Survival Rates by Stage
The numbers here are genuinely encouraging compared to most cancers. Based on data from patients diagnosed between 2015 and 2021, the five-year relative survival rates break down like this:
- Localized (still in the testicle): 99%
- Regional (spread to nearby lymph nodes): 96%
- Distant (spread to lungs, brain, or distant lymph nodes): 72%
Most testicular cancers are caught at the localized stage, which is a big part of why overall outcomes are so favorable. Even regional spread, which sounds alarming, still has a 96% survival rate because testicular cancer responds exceptionally well to treatment.
Seminoma vs. Non-Seminoma
Testicular cancers fall into two main categories, and the type you have affects how aggressive it is and how it’s treated. Seminomas tend to grow more slowly, respond well to both radiation and chemotherapy, and are less likely to spread to distant parts of the body. No seminoma cases are even classified as “poor prognosis” under international staging systems.
Non-seminomas are more variable. They can contain tissue types that resist chemotherapy and sometimes require additional surgery to remove. For metastatic non-seminoma, five-year survival ranges from 92% to 94% in good-prognosis cases down to about 71% in poor-prognosis cases. The difference largely comes down to where the cancer has spread and how elevated certain blood markers are at diagnosis.
How It Spreads
Testicular cancer follows a fairly predictable path. It first moves to lymph nodes near the kidneys, in an area called the retroperitoneum. From there, the most common sites of further spread are the lungs, chest lymph nodes, neck lymph nodes, and in rarer cases, the brain. Because the spread pattern is well understood, doctors can monitor and catch progression early, which is one reason treatment remains effective even after the cancer has moved beyond the testicle.
What Treatment Looks Like
The first step is almost always surgical removal of the affected testicle. Recovery from this procedure typically takes several weeks, with most people returning to physical activity and sex within three to four weeks. Losing one testicle does not usually cause a significant drop in testosterone, because the remaining testicle compensates. Hormone-related side effects are primarily a concern when both testicles are removed.
What happens next depends on the stage and type. Some people go on active surveillance, meaning regular imaging, blood tests, and checkups to watch for recurrence rather than receiving additional treatment right away. Others need chemotherapy, radiation, or further surgery. Chemotherapy is the standard approach for cancer that has spread, and while it’s effective, it comes with the most significant side effects.
Recurrence Risk
For early-stage disease (stage I, where the cancer hasn’t visibly spread), the risk of recurrence on surveillance ranges from about 12% to 20% for seminomas, with the largest study of over 1,500 patients showing a 17% relapse rate. Non-seminomas carry a higher recurrence risk of around 30% overall, and that number climbs to 50% when tumor cells have invaded nearby blood or lymph vessels.
The important context is that recurrence doesn’t mean the cancer becomes untreatable. Active surveillance is designed specifically to catch relapses early, when they’re still highly curable. That’s why doctors consider surveillance a safe option for many early-stage patients rather than jumping straight to chemotherapy.
The Real Cost: Fertility
This is where testicular cancer can hit hardest, especially for younger men. Only about 48% of men who receive standard platinum-based chemotherapy successfully father a child afterward, compared to over 90% of men who only have surgery and go on surveillance. Sperm production does recover over time for many people. About 48% regain normal sperm counts within two years of finishing chemo, and that rises to 80% by five years. But roughly one in four men treated with certain chemotherapy drugs remain unable to produce sperm at the five-year mark.
Sperm banking before treatment starts is the most straightforward and cost-effective way to preserve the option of having biological children. Both major oncology and reproductive medicine organizations recommend that every patient be offered fertility counseling before chemotherapy or radiation begins. If this matters to you, bring it up before your first treatment, not after.
Long-Term Health After Treatment
One reassuring finding: five-year testicular cancer survivors do not appear to have higher rates of heart disease, heart attack, heart failure, or stroke compared to men who never had cancer. This is notable because chemotherapy for other cancers often carries cardiovascular risks. Some survivors do experience hearing changes, likely related to platinum-based chemotherapy, though the overall rates remain low.
The risk of developing a second, unrelated cancer after treatment is difficult to quantify because it happens infrequently. Studies have found too few cases to draw firm conclusions, which itself suggests the risk is small.
Symptoms to Recognize
Testicular cancer typically shows up as a painless lump or swelling in one testicle. You might also notice a change in how the testicle feels, a dull ache in your lower abdomen or groin, sudden fluid buildup in the scrotum, or general discomfort in the testicle. Pain is not always present, which is why a lump alone is worth getting checked. Most lumps turn out to be something else, but the ones that are cancer respond best to early treatment.